{"id":1567,"date":"2018-12-10T15:44:56","date_gmt":"2018-12-10T06:44:56","guid":{"rendered":"[homeurl]\/?page_id=1567"},"modified":"2018-12-10T15:44:56","modified_gmt":"2018-12-10T06:44:56","slug":"sympo_program_en","status":"publish","type":"page","link":"https:\/\/www.jmac.or.jp\/en\/sympo_program_en\/","title":{"rendered":"The 6th JMAC Symposium Program"},"content":{"rendered":"

The 6th<\/sup> JMAC Symposium Program<\/h3>\n

PDF is here<\/a><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
The 6th JMAC Symposium Program Day 1<\/strong><\/td>\n<\/tr>\n
Thursday, January 24, 2019<\/td>\n<\/tr>\n
Day1<\/strong><\/td>\nRegistration\uff1a9:30\uff5e10:00\u3000<\/strong><\/td>\nTokyo International Forum B5<\/strong><\/td>\n<\/tr>\n
Session\uff11: International standards and innovation in biotech field<\/strong>
\nChair\uff1aDr. Hiroki Nakae\uff08JMAC\uff09<\/strong><\/td>\n<\/tr>\n
\n

10:00\uff5e10:05<\/p>\n<\/td>\n

Welcome Remarks
\n<\/strong>Ministry of Economy, Trade and Industry (METI)<\/td>\n<\/tr>\n
\n

10:05\uff5e10:10<\/p>\n<\/td>\n

Introduction of Session 1 “International standards and innovation in biotech field”
\n<\/strong>Dr. Hiroki Nakae\uff0fJMAC<\/td>\n<\/tr>\n
\n

10:10\uff5e10:40<\/p>\n<\/td>\n

Conformity assessment in biobanking spectrum
\n<\/strong>Dr. Koh Furuta\uff0fKanagawa Cancer Center<\/td>\n<\/tr>\n
\n

10:40\uff5e11:10<\/p>\n<\/td>\n

A Summary of Current Standardization Activities in ISO\/TC276 Biotechnology
\n<\/strong>Clare M. Allocca\uff0fNational Institute of Standards & Technology (NIST, USA)<\/td>\n<\/tr>\n
\n

11:10\uff5e11:30<\/p>\n<\/td>\n

International standardization for cell-based assay using bioluminescence measurement
\n<\/strong>Dr. Naohiro Noda\uff0fAIST<\/td>\n<\/tr>\n
\n

11:30\uff5e11:50<\/p>\n<\/td>\n

Safety Assessment in the Coming Era of the Precision Medicine
\n<\/strong>Dr. Yuko Sekino\uff0fTokyo University<\/td>\n<\/tr>\n
\n

11:50\uff5e13:10<\/p>\n<\/td>\n

Break and Posters<\/strong><\/td>\n<\/tr>\n
\n

13:10\uff5e13:40<\/p>\n<\/td>\n

Two-Tailed PCR for precision diagnostics
\n<\/strong>Dr. Mikael Kubista\uff0fTATAA Biocenter\uff08Sweden\uff09<\/td>\n<\/tr>\n
13:40\uff5e14:10<\/td>\nFIRM (The Forum for Innovative Regenerative Medicine) pursuing international standardization
\n<\/strong>Mr. Tatsuo Heki\uff0fForum for Innovative Regenerative Medicine\uff08FIRM\uff09\u30fbFUJIFILM Corporation
\nDr. Yutaka Yanagita\uff0fForum for Innovative Regenerative Medicine\uff08FIRM\uff09\u30fbAstellas Pharma Inc.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Session\uff12: AMED miRNA Project Reports Part I<\/strong>
\nDr. Takahiro Ochiya\uff08National Cancer Center\uff09<\/strong><\/td>\n<\/tr>\n
\n

14:10\uff5e14:15<\/p>\n<\/td>\n

Welcome Remarks<\/strong>
\nMr. Naoyuki Yamada\uff0fAMED<\/td>\n<\/tr>\n
\n

14:15\uff5e14:25<\/p>\n<\/td>\n

Introduction of Session 2 “AMED miRNA Project Reports Part I”<\/strong>
\nDr. Takahiro Ochiya\uff0fNational Cancer Center<\/td>\n<\/tr>\n
\n

14:25\uff5e14:55<\/p>\n<\/td>\n

Recent progress of serum miRNA profiling for the early stage cancer detection<\/strong>
\nDr. Juntaro Matsuzaki\uff0fNational Cancer Center<\/td>\n<\/tr>\n
\n

14:55\uff5e15:25<\/p>\n<\/td>\n

The role of liquid biopsy in taking precision medicine to new heights<\/strong>
\nDr. Hiroki Ochiai\uff0fNational Cancer Center\u30fbKitasato University Kitasato Institute Hospital<\/td>\n<\/tr>\n
\n

15:25\uff5e15:55<\/p>\n<\/td>\n

Break and Posters<\/strong><\/td>\n<\/tr>\n
\n

15:55\uff5e16:25<\/p>\n<\/td>\n

Development of a combination marker search algorithm for multiple diseases<\/strong>
\nMr. Hitoshi Fujimiya\uff0fDynacom Co., Ltd.<\/td>\n<\/tr>\n
\n

16:25\uff5e16:55<\/p>\n<\/td>\n

The possibilities and issues of Medical AI<\/strong>
\nDr. Nobuyuki Ota\uff0fPreferred Networks America, Inc.<\/td>\n<\/tr>\n
\n

16:55\uff5e17:25<\/p>\n<\/td>\n

Detection of microRNA biomarker for dementia<\/strong>
\nDr. Shunpei Niida\uff0fNational Center for Geriatrics and Gerontology<\/td>\n<\/tr>\n
\n

17:25\uff5e17:30<\/p>\n<\/td>\n

Wrap up Remarks of Session 2<\/strong>
\nDr. Takahiro Ochiya\uff0fNational Cancer Center<\/td>\n<\/tr>\n
18:00\uff5e19:30<\/td>\nReception<\/strong>
\nLounge, Tokyo International Forum
\n\u203bRegistration required<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
The 6th JMAC Symposium Program Day 2<\/strong><\/td>\n<\/tr>\n
Friday, January 25, 2019<\/td>\n<\/tr>\n
Day2<\/strong><\/td>\nRegistration\uff1a9:30\uff5e10:00\u3000<\/strong><\/td>\nTokyo International Forum B5<\/strong><\/td>\n<\/tr>\n
Session3: AMED miRNA Project Reports Part II<\/strong>
\nChair\uff1aDr. Hiroki Nakae\uff08JMAC\uff09<\/strong><\/td>\n<\/tr>\n
\n

10:00\uff5e10:10<\/p>\n<\/td>\n

Welcome Remarks<\/strong>
\nDr. Saito Shiro\uff0fPresident of JMAC, Toshiba Corporation<\/td>\n<\/tr>\n
\n

10:10\uff5e10:15<\/p>\n<\/td>\n

Introduction of Session 3 and follow-up of previous day<\/strong>
\nDr. Hiroki Nakae\uff0fJMAC<\/td>\n<\/tr>\n
\n

10:15\uff5e10:45<\/p>\n<\/td>\n

Development of DNA chip for the diagnosis with circulating miRNA<\/strong>
\nDr. Satoko Takizawa\uff0fToray Industries, Inc.<\/td>\n<\/tr>\n
\n

10:45\uff5e11:00<\/p>\n<\/td>\n

Development of electrochemical miRNA detection technology<\/strong>
\nDr. Kouji Hashimoto\uff0fToshiba Corporation<\/td>\n<\/tr>\n
\n

11:00\uff5e11:15<\/p>\n<\/td>\n

Development of a non-PCR based miRNA quantification system for bedside testing<\/strong>
\nDr. Akio Kobori\uff0fKyoto Institute of Technology
\nDr. Yuichiro Noda\uff0fArkray Inc.<\/td>\n<\/tr>\n
\n

11:15\uff5e11:30<\/p>\n<\/td>\n

Development of automated nucleic acid extraction system for exosome and miRNA from body fluids for clinical site inspection<\/strong>
\nDr. Kazumi Sawakami\uff0fPrecision System Science Co., Ltd.<\/td>\n<\/tr>\n
\n

11:30\uff5e12:00<\/p>\n<\/td>\n

miRNA Biomarkers and International Standardization<\/strong>
\nDr. Hiroki Nakae\uff0fJMAC<\/td>\n<\/tr>\n
12:00\uff5e13:20<\/td>\n\n

Break and Posters<\/strong><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n
Session 4: “Expectations for Liquid Biopsy Technology\u201d<\/strong>
\nChair\uff1aDr. Takahiro Ochiya\uff08National Cancer Center\uff09<\/strong><\/td>\n<\/tr>\n
\n

13:20\uff5e13:25<\/p>\n<\/td>\n

Welcome Remarks<\/strong>
\nDr. Hiroshi Kato\uff0fYamaguchi University<\/td>\n<\/tr>\n
\n

13:25\uff5e13:55<\/p>\n<\/td>\n

Advances in liquid biopsy for early detection of cancer<\/strong>
\nDr. Takahiro Ochiya\uff0fNational Cancer Center<\/td>\n<\/tr>\n
\n

13:55\uff5e14:25<\/p>\n<\/td>\n

Unveiling of Extracellular miRNA Profiles of Breast Cancer<\/strong>
\nDr. Tang-Long Shen\uff0fNational Taiwan University\uff08Taiwan\uff09<\/td>\n<\/tr>\n
\n

14:25\uff5e14:55<\/p>\n<\/td>\n

Rigor and Reproducibility for Liquid Biopsy<\/strong>
\nDr. Matthew Young\uff0fNational Cancer Institute\uff08USA\uff09<\/td>\n<\/tr>\n
\n

14:55\uff5e15:25<\/p>\n<\/td>\n

Break and Posters<\/strong><\/td>\n<\/tr>\n
\n

15:25\uff5e15:55<\/p>\n<\/td>\n

Application of Liquid Biopsy to Clinical Laboratory Testings<\/strong>
\nDr. Masato Maekawa\uff0fHamamatsu University School of Medicine<\/td>\n<\/tr>\n
\n

15:55\uff5e16:25<\/p>\n<\/td>\n

Cancer precision medicine based on liquid biopsy<\/strong>
\nDr. Kazuto Nishio\uff0fKindai University<\/td>\n<\/tr>\n
16:25\uff5e17:15<\/td>\nPanel discussion “Expectations for Liquid Biopsy Technology”<\/strong>
\nDr. Ochiya, Dr. Nakae, Dr. Nishio, Dr. Shen, Dr. Young, Dr. Maekawa<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

The 6th JMAC Symposium Program PDF is here The 6th JMAC Symposium Program Day 1 Thursday, January 24, 2019 Day […]<\/p>\n","protected":false},"author":143,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"ngg_post_thumbnail":0,"_locale":"en_US","_original_post":"1241","sns_share_botton_hide":"","vkExUnit_sns_title":"","_vk_print_noindex":"","sitemap_hide":"","vkExUnit_sitemap":"","_veu_custom_css":".program_title{\r\n color:#26499d;\r\n background-color:#a7d28d;\r\n text-align: center;\r\n}\r\n.program_day{\r\n text-align: center;\r\n}\r\n.program_session{\r\n background-color:#a7d28d;\r\n}\r\n.program_break{\r\n background-color:#efefef;\r\n}\r\n.program_reception{\r\n background-color:#efefef;\r\n}\r\n.program_red{\r\n color:#ff0000;\r\n}","veu_display_promotion_alert":"","_exclude_from_list_pages":"","vkexunit_cta_each_option":"","vkExUnit_childPageIndex":"","vkExUnit_pageList_ancestor":"","vkExUnit_contact_enable":"","footnotes":""},"class_list":["post-1567","page","type-page","status-publish","hentry","en-US"],"veu_head_title_object":{"title":"","add_site_title":""},"_links":{"self":[{"href":"https:\/\/www.jmac.or.jp\/wp-json\/wp\/v2\/pages\/1567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.jmac.or.jp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.jmac.or.jp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.jmac.or.jp\/wp-json\/wp\/v2\/users\/143"}],"replies":[{"embeddable":true,"href":"https:\/\/www.jmac.or.jp\/wp-json\/wp\/v2\/comments?post=1567"}],"version-history":[{"count":1,"href":"https:\/\/www.jmac.or.jp\/wp-json\/wp\/v2\/pages\/1567\/revisions"}],"predecessor-version":[{"id":1568,"href":"https:\/\/www.jmac.or.jp\/wp-json\/wp\/v2\/pages\/1567\/revisions\/1568"}],"wp:attachment":[{"href":"https:\/\/www.jmac.or.jp\/wp-json\/wp\/v2\/media?parent=1567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}